Inhibition of Akt Attenuates RPO-Induced Cardioprotection

Previous studies have shown that red palm oil (RPO) supplementation protected rat hearts against ischaemia-reperfusion injury. Evidence from these studies suggested that Akt may be partly responsible for the observed protection. The aim of the current study was therefore to prove or refute the invol...

Full description

Saved in:
Bibliographic Details
Main Authors: Emma Katengua-Thamahane, Anna-Mart Engelbrecht, Adriaan J. Esterhuyse, Jacques Van Rooyen
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2012/392457
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849685612518440960
author Emma Katengua-Thamahane
Anna-Mart Engelbrecht
Adriaan J. Esterhuyse
Jacques Van Rooyen
author_facet Emma Katengua-Thamahane
Anna-Mart Engelbrecht
Adriaan J. Esterhuyse
Jacques Van Rooyen
author_sort Emma Katengua-Thamahane
collection DOAJ
description Previous studies have shown that red palm oil (RPO) supplementation protected rat hearts against ischaemia-reperfusion injury. Evidence from these studies suggested that Akt may be partly responsible for the observed protection. The aim of the current study was therefore to prove or refute the involvement of Akt in the RPO-induced cardioprotection by administration of a specific Akt inhibitor (A6730). Male Wistar rats were randomly divided into 2 groups: a control group receiving standard rat chow and an experimental group receiving standard rat chow plus 2 mL RPO for six weeks. Hearts were excised and mounted on the Langendorff perfusion system. Functional recovery was documented. A different set of hearts were freeze-clamped to assess total and phosphorylation status of Akt. Another set of hearts were subjected to the same perfusion conditions with addition of A6730. Hearts from this protocol were freeze-clamped and assessed for total and phospho-Akt. RPO improved functional recovery which was associated with increased phosphorylation of Akt on Ser473 and Thr308 residues. Blockade of Akt phosphorylation caused poor functional recovery. For the first time, these results prove that Akt plays an important role in the RPO-induced cardioprotection.
format Article
id doaj-art-c506e830fb954876bbb06726690b6dbe
institution DOAJ
issn 2090-8016
2090-0597
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Cardiology Research and Practice
spelling doaj-art-c506e830fb954876bbb06726690b6dbe2025-08-20T03:23:04ZengWileyCardiology Research and Practice2090-80162090-05972012-01-01201210.1155/2012/392457392457Inhibition of Akt Attenuates RPO-Induced CardioprotectionEmma Katengua-Thamahane0Anna-Mart Engelbrecht1Adriaan J. Esterhuyse2Jacques Van Rooyen3Experimental Anti-oxidant Research Division, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Symphony Road, Western Cape, Bellville 7535, South AfricaDepartment of Physiological Sciences, University of Stellenbosch, Stellenbosch 7600, South AfricaExperimental Anti-oxidant Research Division, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Symphony Road, Western Cape, Bellville 7535, South AfricaExperimental Anti-oxidant Research Division, Department of Biomedical Sciences, Faculty of Health and Wellness Sciences, Cape Peninsula University of Technology, Symphony Road, Western Cape, Bellville 7535, South AfricaPrevious studies have shown that red palm oil (RPO) supplementation protected rat hearts against ischaemia-reperfusion injury. Evidence from these studies suggested that Akt may be partly responsible for the observed protection. The aim of the current study was therefore to prove or refute the involvement of Akt in the RPO-induced cardioprotection by administration of a specific Akt inhibitor (A6730). Male Wistar rats were randomly divided into 2 groups: a control group receiving standard rat chow and an experimental group receiving standard rat chow plus 2 mL RPO for six weeks. Hearts were excised and mounted on the Langendorff perfusion system. Functional recovery was documented. A different set of hearts were freeze-clamped to assess total and phosphorylation status of Akt. Another set of hearts were subjected to the same perfusion conditions with addition of A6730. Hearts from this protocol were freeze-clamped and assessed for total and phospho-Akt. RPO improved functional recovery which was associated with increased phosphorylation of Akt on Ser473 and Thr308 residues. Blockade of Akt phosphorylation caused poor functional recovery. For the first time, these results prove that Akt plays an important role in the RPO-induced cardioprotection.http://dx.doi.org/10.1155/2012/392457
spellingShingle Emma Katengua-Thamahane
Anna-Mart Engelbrecht
Adriaan J. Esterhuyse
Jacques Van Rooyen
Inhibition of Akt Attenuates RPO-Induced Cardioprotection
Cardiology Research and Practice
title Inhibition of Akt Attenuates RPO-Induced Cardioprotection
title_full Inhibition of Akt Attenuates RPO-Induced Cardioprotection
title_fullStr Inhibition of Akt Attenuates RPO-Induced Cardioprotection
title_full_unstemmed Inhibition of Akt Attenuates RPO-Induced Cardioprotection
title_short Inhibition of Akt Attenuates RPO-Induced Cardioprotection
title_sort inhibition of akt attenuates rpo induced cardioprotection
url http://dx.doi.org/10.1155/2012/392457
work_keys_str_mv AT emmakatenguathamahane inhibitionofaktattenuatesrpoinducedcardioprotection
AT annamartengelbrecht inhibitionofaktattenuatesrpoinducedcardioprotection
AT adriaanjesterhuyse inhibitionofaktattenuatesrpoinducedcardioprotection
AT jacquesvanrooyen inhibitionofaktattenuatesrpoinducedcardioprotection